Doll Capital Management
DCM
Doll Capital Management, commonly known as DCM, is a venture capital fund co-founded by Hans Tung (林欣禾) as founding and managing partner . Hurst Lin (林欣禾) serves as a director partner, having founded and led DCM China in 2006 after leaving his role as COO of Sina . The firm was originally established in 1996 in Silicon Valley by Dixon Doll and David Chao (赵克仁) .
DCM operates with a notably lean, "sniper-style" approach—its China investment team has typically stayed under ten people, with roughly ten deals per year and no dedicated post-investment staff, leaving GP oversight for portfolio support . In November 2024, DCM announced it would split off its angel and seed fund team into a separate independent investment company led by partner Osuke Honda (本多央辅), focused primarily on Japan; this restructuring affected only the approximately $100 million A Fund IV, while DCM's main funds and first three exploratory funds continued unchanged . The core investment decision-making body remained composed of David Chao, Hurst Lin, and Ramon Zeng (曾振宇) .
AI-generated — may contain errors, please verify.
Coverage
A Sidebar Conversation with Master Dong on 20 Years of Chinese Venture Capital
Happy New Year!
elsewhere别处发生·Conversation with YouWare's Ming Chaoping: They're Skeptical That AI Coding Is a New Form of Creation — and I'm Thrilled | Z Talk
The promising AI product founder chose a path few others dared to take.
真格基金·Exclusive | DCM Ventures Splits Up Too, But Still Committed to Supporting Global Chinese Entrepreneurs
Go against the grain.
暗涌Waves·200 Days of Frenzy: China's LLM Wars Stuck in a Stalemate
Consensus can form quickly — and dissolve just as fast.
暗涌Waves·How 28 Young People Spent 33 Hours on an Island
A celebration means something when it's shared.
暗涌Waves·AI image generation technology provider Tiamat has raised an additional A+ round investment, led by Linear Capital
Launching a web version to accelerate tool-ification
线性资本·Linear Capital Perspectives | Rather Than Trends or Windfalls, We Focus on Whether Frontier Technology Can Deliver 10x or 100x Efficiency Gains for Industries
Last week, at the "16th China Investment Annual Conference & Annual Summit" hosted by ChinaVenture, Harry Wang, CEO and Partner of Linear Capital, joined a panel discussion on "China's Digital-Intelligent Transformation and Industrial Restructuring" and shared Linear Capital's perspective on the topic.
线性资本·June, Vitality | 5Y News Monthly
The big news from last month.
五源资本·5Y News | Sensors Data Closes $200 Million Series D Round
Boost efficiency through scientific methods.
五源资本·A grain of sand for the era, a mountain for USD funds
To survive in an era of sweeping change, keeping your eyes on the ground is never enough — you have to look up at the sky too.
暗涌Waves·September, When Hope Will Break Through Like the Sun | 5Y News Monthly
The big news from last month.
五源资本·5Y News | Galixir Completes New Strategic Funding Round, Continues Advancing Drug R&D Pipeline
5Y Capital continues to watch for opportunities where information technology can be applied in healthcare and medicine.
五源资本·5Y News | Galixir Announces Completion of Tens of Millions of USD in Funding, with Continued Backing from 5Y Capital
Breaking the Bottleneck in New Drug R&D with "AI+"
五源资本·What were the big moments for us last month? | Light Moments August Report
IPOs, Funding, Strategic Partnerships, Awards... August in Review
五源资本·The Collision of AI and Pharmaceuticals: Galaxy Pharma Tech Raises Nearly $10 Million in Funding | Light Moments
Galixir announced the completion of a nearly $10 million Pre-A funding round. The round was co-led by Source Code Capital and DCM, with 5Y Capital participating as a follow-on investor. Gaorong Capital, the lead investor in the company's angel round, continued to increase its stake.
五源资本·Healthcare Big Data Risk Control Provider "Zhanlü Data" Closes Nearly RMB 100 Million Series B Round
Dedicated to building a fair, accessible, and systematically continuous health protection ecosystem
高榕创投·















